Study finds drug resistance to fight lung cancer

When a person is diagnosed with non-small cell lung cancer, one of the two primary types of lung cancer, there is a 70-80 per cent risk that cancer will acquire resistance to the initial medication therapy used to treat it after 14 months

Related Keywords

Raghuraman Kannan ,Sharonr Bukstein ,Cancer Research ,University Of Missouri School Medicine ,National Cancer Institute ,Missouri School ,Study ,Kinds ,Drug ,Resistance ,O ,Flight ,Young ,Dancer ,News ,Ews India ,